Stage IV Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
1 clinical trials · Condition
◉ Watch Stage IV Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
| Record | Firm | Date |
|---|---|---|
| Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer (NCT01935934) | National Cancer Institute (NCI) | 2013-05-08 |
Track Stage IV Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage automatically
Every clearance here is in the API, with alerts when new ones post.